Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Hormone-related and drug-induced osteoporosis: a cellular and molecular overview
LT Wang, LR Chen, KH Chen - International Journal of Molecular …, 2023 - mdpi.com
Osteoporosis resulting from an imbalance of bone turnover between resorption and
formation is a critical health issue worldwide. Estrogen deficiency following a nature aging …
formation is a critical health issue worldwide. Estrogen deficiency following a nature aging …
[SÁCH][B] Development and Evaluation of a Nurse Practitioner-Directed Bone Health Screening for Prostate Cancer Patients in an Oncology Practice
A Adewale - 2023 - search.proquest.com
Bone health impairment is a recurring detrimental outcome of prostate cancer cells' high
bone tropism. The impairment is further exacerbated by administering androgen deprivation …
bone tropism. The impairment is further exacerbated by administering androgen deprivation …
Comparative pharmacokinetic study of bicalutamide administration alone and in combination with vitamin D in rats
W Shi, H Di, B Pang, H **, H Liu, B Qiu… - Acta …, 2021 - akjournals.com
Bicalutamide (BCL) has been approved for treatment of advanced prostate cancer (Pca),
and vitamin D is inevitably used in combination with BCL in Pca patients for skeletal or anti …
and vitamin D is inevitably used in combination with BCL in Pca patients for skeletal or anti …
Bone Mineral Density in Patients with Metastatic Prostate Cancer with or without Androgen Deprivation Therapy
I Hyder, A Hafeez, M Waqas - Medical Forum Monthly, 2022 - medicalforummonthly.com
Objective: To evaluate the bone mineral density in patients of malignant prostate cancer with
and without use of androgen deprivation therapy. Study Design: Case control study Place …
and without use of androgen deprivation therapy. Study Design: Case control study Place …